Aptinyx Inc reported $-14657000 in EBIT for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acadia Pharmaceuticals ACAD:US USD -30866000 2.78M
Biogen BIIB:US USD 872.1M 68.8M
Cara Therapeutics CARA:US USD -23845000 19.37M
Daiichi Sankyo 4568:JP JPY 61.2B 26.82B
Eli Lilly And LLY:US USD 1.95B 294.9M
Halozyme Therapeutics HALO:US USD 83.69M 49.63M
Intra Cellular Therapies ITCI:US USD -55629000 32.29M
IONIS PHARMACEUT IONS:US USD -59154000 26.36M
Marinus Pharmaceuticals MRNS:US USD -30099000 6.67M
Neurocrine Biosciences NBIX:US USD 87.8M 33.1M
Novartis NOVN:VX USD 3.33B 8M
Ultragenyx Pharmaceutical RARE:US USD -225066000 83.47M
Vertex Pharmaceuticals VRTX:US USD 1.13B 7.4M